Tomoki Makino

23PUBLICATIONS
26CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Apr 08, 2026
PD-1 antibody-bound progenitor-exhausted CD8+ T cells in lymph nodes boost PD-1-blockade anti-tumor immunity in gastrointestinal cancer.

Yohei Nose, Yoshiaki Yasumizu, Takuro Saito

|Mar 30, 2026
Correction: APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation.

Teruyuki Kobayashi, Tomoki Makino, Kotaro Yamashita

|Jan 16, 2026
A randomized controlled trial evaluating the effects of anamorelin in postoperative patients with upper gastrointestinal cancer: protocol for the CLEAR-UP study.

Kotaro Yamashita, Kazutaka Nishio, Shosuke Mizutani

|Dec 16, 2025
A retrospective cohort study on short-term outcomes after oesophagectomy for cancer in Japan.

Tomoki Makino, Hideki Endo, Hiroyuki Yamamoto

|Dec 05, 2025
Conversion surgery following immunochemotherapy for initially unresectable/recurrent esophageal cancer.

Tomoki Makino, Shigeto Nakai, Takaomi Hagi

|Nov 11, 2025
Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy.

Naoki Ikenaga, Tsuyoshi Takahashi, Koji Tanaka

Pageof 4

Frequent Collaborators

10 joint publications

Tsuyoshi Takahashi

5 joint publications

Yukinori Kurokawa

4 joint publications

Masaaki Motoori

4 joint publications

Hidetoshi Eguchi